NDC 70860-220

Thiotepa

Thiotepa

Thiotepa is a Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Athenex Pharmaceutical Division, Llc.. The primary component is Thiotepa.

Product ID70860-220_6a12eeea-ab98-42fe-8c5b-817d884dd44b
NDC70860-220
Product TypeHuman Prescription Drug
Proprietary NameThiotepa
Generic NameThiotepa
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Marketing Start Date2022-10-15
Marketing CategoryANDA /
Application NumberANDA211831
Labeler NameAthenex Pharmaceutical Division, LLC.
Substance NameTHIOTEPA
Active Ingredient Strength15 mg/1.5mL
Pharm ClassesAlkylating Activity [MoA], Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70860-220-02

1 VIAL, SINGLE-DOSE in 1 CARTON (70860-220-02) > 1.5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-10-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Thiotepa" or generic name "Thiotepa"

NDCBrand NameGeneric Name
0143-9309ThiotepaThiotepa
0143-9565ThiotepaThiotepa
25021-246ThiotepaThiotepa
43598-171ThiotepaThiotepa
43598-650ThiotepaThiotepa
54879-014ThiotepaThiotepa
65219-029ThiotepaThiotepa
68083-446ThiotepaThiotepa
68083-503ThiotepaThiotepa
69539-123ThiotepaThiotepa
69539-124ThiotepaThiotepa
70860-220Thiotepathiotepa
72205-045ThiotepaThiotepa
72205-046ThiotepaThiotepa
53964-001TEPADINATHIOTEPA
53964-002TEPADINATHIOTEPA
70121-1630TEPADINATHIOTEPA
70121-1631TEPADINATHIOTEPA

Trademark Results [Thiotepa]

Mark Image

Registration | Serial
Company
Trademark
Application Date
THIOTEPA
THIOTEPA
73471323 not registered Dead/Abandoned
AMERICAN CYANAMID COMPANY
1984-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.